propranolol has been researched along with bevantolol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Corey, RM; Essenburg, AD; Hastings, SG; Pettway, CE; Smith, RD; Tessman, DK | 1 |
| Kigoshi, S; Muramatsu, I; Takita, M | 1 |
| Abiko, Y; Hino, T; Ichihara, K; Sakai, K | 1 |
| Fernandez, PG; Nath, C; Snedden, W | 1 |
| Maclean, D | 1 |
| Algarra, FJ; Bordes, P; Estruch, G; Ferrer, J; Gimeno, JV; Mainer, V; Olague, J; Serra, J | 1 |
| Brooks, HL; Gross, GJ; Hardman, HF; Jesmok, GJ; Warltier, DC | 1 |
| Baldwin, CJ; Gribbin, HR; Mackay, AD; Tattersfield, AE | 1 |
| Arakawa, K; Kajiyama, G; Koga, S; Kusukawa, R; Mori, H; Ogawa, N; Sasaki, J; Takagi, R; Tanaka, N | 1 |
| Akaike, N; Kobayashi, T; Miyake, N; Nishioka, K; Omura, T | 1 |
| Toleikis, PM; Tomlinson, CW | 1 |
| Horinouchi, T; Koike, K; Miwa, S; Morishima, S; Muramatsu, I; Suzuki, F; Tanaka, T; Tanaka, Y | 1 |
5 trial(s) available for propranolol and bevantolol
| Article | Year |
|---|---|
The blood pressure responses of thiazide-resistant hypertensives to a once-a-day bevantolol regimen.
Topics: Adrenergic beta-Antagonists; Adult; Benzothiadiazines; Blood Pressure; Diuretics; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Hypertension; Middle Aged; Propanolamines; Propranolol; Sodium Chloride Symporter Inhibitors | 1987 |
Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Propanolamines; Propranolol; Prospective Studies | 1988 |
Acute, short- and long-term efficacy of oral bevantolol in patients with coronary artery disease: a placebo-controlled, randomized, double-blind study.
Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Forced Expiratory Volume; Heart Rate; Humans; Lung; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Random Allocation; Vital Capacity | 1986 |
Assessment of bronchial beta blockade after oral bevantolol.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Albuterol; Bronchi; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Physical Exertion; Practolol; Propanolamines; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Apolipoproteins; Blood Pressure; Fatty Acids, Nonesterified; Female; Humans; Hypertension; Lipids; Lipoproteins; Male; Middle Aged; Propanolamines; Propranolol; Triglycerides | 1994 |
10 other study(ies) available for propranolol and bevantolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Insulin Antagonists; Isoproterenol; Male; Muscle, Smooth; Practolol; Propanolamines; Propranolol; Trachea; Water-Electrolyte Balance | 1977 |
Selectivity of bevantolol hydrochloride towards alpha- and beta-adrenoceptor subtypes in rat cerebral cortex.
Topics: Adrenergic beta-Antagonists; Animals; Cerebral Cortex; Humans; In Vitro Techniques; Infant, Newborn; Propanolamines; Propranolol; Radioligand Assay; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1992 |
Attenuation of ischaemia-induced regional myocardial acidosis by bevantolol, a beta 1-adrenoceptor antagonist, in dogs.
Topics: Acidosis; Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Disease; Coronary Vessels; Dogs; Female; Heart Rate; Hydrogen-Ion Concentration; Male; Myocardium; Propanolamines; Propranolol | 1989 |
Protection of ischemic myocardium: comparison of effects of propranolol, bevantolol and N-dimethyl propranolol on infarct size following coronary artery occlusion in anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Vessels; Dogs; Female; Hemodynamics; Ligation; Male; Myocardial Infarction; Propanolamines; Propranolol | 1980 |
Ca(2+)-antagonistic action of bevantolol on hypothalamic neurons in vitro: its comparison with those of other beta-adrenoceptor antagonists, a local anesthetic and a Ca(2+)-antagonist.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Calcium Channel Blockers; Hypothalamus, Middle; Lidocaine; Neurons; Nicardipine; Patch-Clamp Techniques; Propanolamines; Propranolol; Rats; Rats, Wistar | 1996 |
Myocardial functional preservation during ischemia: influence of beta blocking agents.
Topics: Adrenergic beta-Antagonists; Animals; Heart; Heart Function Tests; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Propanolamines; Propranolol; Rabbits; Stroke Volume | 1997 |
Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Male; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction | 2007 |